John M. Quillin

857 total citations
53 papers, 635 citations indexed

About

John M. Quillin is a scholar working on Genetics, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, John M. Quillin has authored 53 papers receiving a total of 635 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Genetics, 15 papers in Oncology and 12 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in John M. Quillin's work include BRCA gene mutations in cancer (36 papers), Global Cancer Incidence and Screening (11 papers) and Ethics in Clinical Research (8 papers). John M. Quillin is often cited by papers focused on BRCA gene mutations in cancer (36 papers), Global Cancer Incidence and Screening (11 papers) and Ethics in Clinical Research (8 papers). John M. Quillin collaborates with scholars based in United States, Israel and Canada. John M. Quillin's co-authors include Joann Bodurtha, Donna K. McClish, Diane Wilson, Joseph F. Borzelleca, Rosalie Corona, Thomas J. Smith, Deborah J. Bowen, Vivian M. Rodríguez, Resa M. Jones and Laura A. Siminoff and has published in prestigious journals such as New England Journal of Medicine, American Journal of Preventive Medicine and International Journal of Environmental Research and Public Health.

In The Last Decade

John M. Quillin

49 papers receiving 615 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John M. Quillin United States 17 319 149 115 115 111 53 635
Lisa Kessler United States 15 395 1.2× 188 1.3× 46 0.4× 144 1.3× 89 0.8× 33 760
Jonathon Gray United Kingdom 18 439 1.4× 139 0.9× 93 0.8× 133 1.2× 75 0.7× 41 897
Vickie L. Venne United States 15 536 1.7× 196 1.3× 83 0.7× 138 1.2× 153 1.4× 27 848
Starlene Loader United States 16 317 1.0× 179 1.2× 143 1.2× 114 1.0× 51 0.5× 28 772
Agnes Masny United States 12 625 2.0× 250 1.7× 98 0.9× 129 1.1× 119 1.1× 17 930
Andrea Forman United States 17 543 1.7× 142 1.0× 62 0.5× 172 1.5× 94 0.8× 28 732
Kaaren Watts Australia 19 214 0.7× 195 1.3× 132 1.1× 310 2.7× 57 0.5× 31 797
Beatty G. Watts United States 9 345 1.1× 211 1.4× 72 0.6× 82 0.7× 70 0.6× 10 622
Ruth Bingler United States 7 251 0.8× 50 0.3× 60 0.5× 95 0.8× 44 0.4× 7 449
Lindsey Hoskins United States 12 367 1.2× 81 0.5× 62 0.5× 74 0.6× 62 0.6× 17 506

Countries citing papers authored by John M. Quillin

Since Specialization
Citations

This map shows the geographic impact of John M. Quillin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John M. Quillin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John M. Quillin more than expected).

Fields of papers citing papers by John M. Quillin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John M. Quillin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John M. Quillin. The network helps show where John M. Quillin may publish in the future.

Co-authorship network of co-authors of John M. Quillin

This figure shows the co-authorship network connecting the top 25 collaborators of John M. Quillin. A scholar is included among the top collaborators of John M. Quillin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John M. Quillin. John M. Quillin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Smith, Steven C., et al.. (2025). A pathologist’s primer on implementing new standard-of-care molecular biomarker testing for precision prostate cancer management. American Journal of Clinical Pathology. 163(5). 649–655.
3.
Sheppard, Vanessa B., et al.. (2023). Addressing disparities in the uptake of genetic counseling and testing in African American women; rationale, design and methods. Contemporary Clinical Trials. 130. 107210–107210. 1 indexed citations
5.
Quillin, John M., et al.. (2019). Awareness and acceptability of population-based screening for pathogenic BRCA variants: Do race and ethnicity matter?. Gynecologic Oncology. 154(2). 383–387. 14 indexed citations
6.
Lewandowski, Raymond, et al.. (2019). Recontacting patients for multigene panel testing in hereditary cancer: Efficacy and insights. Journal of Genetic Counseling. 28(6). 1198–1207. 7 indexed citations
7.
Quillin, John M., et al.. (2018). The Changing Age of Individuals Seeking Presymptomatic Genetic Testing for Huntington Disease. Journal of Genetic Counseling. 27(5). 1157–1166. 8 indexed citations
8.
Levenson, James L., et al.. (2017). Direct-to-Consumer Genetic Testing and Orphan Drug Development. Genetic Testing and Molecular Biomarkers. 21(8). 456–463. 2 indexed citations
9.
Rodríguez, Vivian M., Rosalie Corona, Joann Bodurtha, & John M. Quillin. (2016). Family Ties: The Role of Family Context in Family Health History Communication About Cancer. Journal of Health Communication. 21(3). 346–355. 22 indexed citations
10.
Rodríguez, Vivian M., et al.. (2014). What Women Think: Cancer Causal Attributions in a Diverse Sample of Women. Journal of Psychosocial Oncology. 33(1). 48–65. 6 indexed citations
11.
Rafie, Carlin, et al.. (2014). Reaching Hard to Reach Populations with Hard to Communicate Messages: Efficacy of a Breast Health Research Champion Training Program. Journal of Cancer Education. 30(3). 599–606. 6 indexed citations
12.
Quillin, John M., et al.. (2013). Patient-reported hereditary breast and ovarian cancer in a primary care practice. Journal of Community Genetics. 5(2). 179–183. 10 indexed citations
13.
Quillin, John M., Joann Bodurtha, & Thomas J. Smith. (2011). Genetic Screening and DNA Banking at the End of Life #206. Journal of Palliative Medicine. 14(5). 656–657. 5 indexed citations
14.
Quillin, John M., Joann Bodurtha, Laura A. Siminoff, & Thomas J. Smith. (2011). Physicians' Current Practices and Opportunities for DNA Banking of Dying Patients With Cancer. Journal of Oncology Practice. 7(3). 183–187. 18 indexed citations
15.
Quillin, John M., Joann Bodurtha, Laura A. Siminoff, & Thomas J. Smith. (2010). Exploring Hereditary Cancer Among Dying Cancer Patients—A Cross‐Sectional Study of Hereditary Risk and Perceived Awareness of DNA Testing and Banking. Journal of Genetic Counseling. 19(5). 497–525. 18 indexed citations
16.
Quillin, John M., Jessica S. Ancker, Karen M. Mustian, et al.. (2009). Health Care System Approaches for Cancer Patient Communication. Journal of Health Communication. 14(sup1). 85–94. 16 indexed citations
17.
Quillin, John M., Diane Wilson, Joseph F. Borzelleca, et al.. (2008). The impact of family history of breast cancer and cancer death on women's mammography practices and beliefs. Genetics in Medicine. 10(8). 621–625. 31 indexed citations
18.
Quillin, John M., Judy L. Silberg, Resa M. Jones, et al.. (2008). Tolerance for ambiguity could influence awareness of breast cancer genetic testing and inform health education. Cancer Causes & Control. 19(10). 1227–1232. 7 indexed citations
19.
Quillin, John M., Viswanathan Ramakrishnan, Joseph F. Borzelleca, et al.. (2006). Paternal Relatives and Family History of Breast Cancer. American Journal of Preventive Medicine. 31(3). 265–268. 26 indexed citations
20.
Quillin, John M., et al.. (2000). College women's awareness and consumption of folic acid for the prevention of neural tube defects. Genetics in Medicine. 2(4). 209–213. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026